Literature DB >> 8889458

Long-term follow-up in cerebral Whipple's disease.

P J Schnider1, E C Reisinger, W Gerschlager, C Müller, T Berger, G J Krejs, E Auff.   

Abstract

OBJECTIVE: To evaluate the long-term outcome in patients with cerebral Whipple's disease. PATIENTS: We reviewed the literature and contacted authors who had reported on cerebral Whipple's disease within the last 10 years. Fifteen patients were evaluated, including one patient treated at our hospital and the one presented in this paper. The mean observation period was 41 +/- 37 months (minimum 1 month, maximum 120 months).
RESULTS: Four patients had improved and were able to pursue an independent lifestyle, three patients had improved but are still dependent on help with simple activities of daily life, one patient was unchanged, and seven patients had died. Patients with initial penicillin alone had a worse prognosis than patients with initial penicillin plus streptomycin.
CONCLUSION: Third generation cephalosporins have been shown to be beneficial in cerebral Whipple's disease, therefore initial antibiotic treatment of Whipple's disease should consist of ceftriaxone (instead of penicillin) combined with streptomycin. Since five of 12 patients (40%) treated with co-trimoxazole (trimethoprim plus sulphamethoxazole) did not respond, we conclude that the combination of trimethoprim and sulphamethoxazole does not prevent or cure central nervous system (CNS) involvement in all patients with Whipple's disease. If CNS relapse occurs during treatment with trimethoprim and sulphamethoxazole, oral third generation cephalosporins might be a useful alternative.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889458

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  15 in total

1.  Whipple's disease in a father-daughter pair.

Authors:  D D Dykman; B A Cuccherini; I J Fuss; L W Blum; J E Woodward; W Strober
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Diffuse lesions in the CNS revealed by MR imaging in a case of Whipple disease.

Authors:  S Kremer; G Besson; B Bonaz; B Pasquier; J F Le Bas; S Grand
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

Review 3.  Whipple's disease and "Tropheryma whippelii".

Authors:  F Dutly; M Altwegg
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

4.  MR imaging of central nervous system Whipple disease: a 15-year review.

Authors:  D F Black; A J Aksamit; J M Morris
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

5.  Whipple's Disease.

Authors:  Klaus Mönkemüller; Lucía C Fry; Steffen Rickes; Peter Malfertheiner
Journal:  Curr Infect Dis Rep       Date:  2006-03       Impact factor: 3.725

6.  [Of bugs and joints. Oligoarthritis caused by Tropheryma whipplei].

Authors:  K Koligi; D Mertz; D Benz; T Vogt; G V Bloemberg; L Winter; A Tyndall; M Battegay; U A Walker
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

Review 7.  Diagnosis and treatment of Whipple's disease.

Authors:  R Singer
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

8.  Whipple's disease: misdiagnosed as sarcoidosis with further tricuspid valve endocarditis and pulmonary embolism - a case report.

Authors:  Robert Berent; Johann Auer; Elisabeth Lassnig; Serge P von Duvillard; Stephen F Crouse; Herwig Tuppy; Bernd Eber
Journal:  BMJ Case Rep       Date:  2009-06-01

9.  Neurologic manifestations of Whipple's disease.

Authors:  Mara M Lugassy; Elan D Louis
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

Review 10.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.